Source comparison
GHRP-6 Acetate vs MK-677: Research Application Comparison
Receptor Target GHS-R1a (ghrelin receptor). Pituitary somatotrophs GHS-R1a (ghrelin receptor). Pituitary and hypothalamus Both target the same receptor; GHRP-6 preserves pulsatility, MK-677 overrides it Plasma Half-Life 20–30 minutes 4–6 hours (tissue effects
This comparison does not assign a generated winner or score.
- Receptor Target
- GHS-R1a (ghrelin receptor). Pituitary somatotrophs
- GHS-R1a (ghrelin receptor). Pituitary and hypothalamus
- Both target the same receptor; GHRP-6 preserves pulsatility, MK-677 overrides it
- Plasma Half-Life
- 20–30 minutes
- 4–6 hours (tissue effects 24+ hours)
- GHRP-6's short half-life enables protocol-specific pulse timing
- GH Release Pattern
- Pulsatile. 5–15× baseline spike, returns to normal in 3–6 hours
- Sustained. 60–70% baseline elevation maintained 24 hours
- GHRP-6 mimics natural physiology; MK-677 creates pharmacological state
- IGF-1 Elevation
- Transient. Rises during GH pulse, normalizes between doses
- Persistent. 40–90% above baseline sustained throughout dosing period
- MK-677 produces cumulative IGF-1 exposure; GHRP-6 produces intermittent peaks
- Administration Route
- Subcutaneous or intramuscular injection
- Oral capsule or suspension
- MK-677's oral bioavailability eliminates injection frequency burden
- Typical Dosing Frequency
- 2–3 times daily (morning, post-exercise, pre-sleep)
- Once daily (usually evening to minimize daytime hunger)
- GHRP-6 requires adherence to multi-dose schedule; MK-677 allows single daily dose
- Storage Requirements
- −20°C lyophilized; 2–8°C reconstituted (28-day use window)
- Room temperature stable for 2 years (sealed, dark container)
- MK-677's stability advantage matters for field studies or labs without freezer access
- Primary Research Use Cases
- Acute anabolic signaling studies, pulsatile GH physiology, nutrient partitioning windows
- Chronic IGF-1 elevation studies, sustained anabolic environment models, long-term collagen/bone research
- Choose GHRP-6 for pulse-dependent mechanisms; MK-677 for cumulative IGF-1-mediated effects
- Appetite Effects
- Minimal (transient ghrelin receptor activation during pulse)
- Pronounced hunger increase (sustained ghrelin signaling throughout 24-hour period)
- MK-677's appetite stimulation can confound metabolic research if not controlled
- Cost Per Research Cycle (30 days)
- $120–$180 (100 mcg × 3 daily doses)
- $80–$140 (25 mg daily dose)
- MK-677 is more cost-effective for long-duration studies